Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.280 -0.435 (-7.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,616,163
Open 5.560
Bid (Size) 5.280 (1)
Ask (Size) 5.300 (9)
Prev. Close 5.715
Today's Range 5.250 - 5.610
52wk Range 3.790 - 12.36
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Under-the-Radar Tech Stocks With Incredible Growth Potential
Just because it's not a household name doesn't mean it's not a magnificent investment. 
Via The Motley Fool
Topics Artificial Intelligence
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Via The Motley Fool

Performance

YTD
-26.8%
-26.8%
1 Month
-2.2%
-2.2%
3 Month
-8.3%
-8.3%
6 Month
-23.3%
-23.3%
1 Year
-31.2%
-31.2%

More News

Read More
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
From Recursion Pharmaceuticals
Via GlobeNewswire
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
Via Benzinga
The Hottest 10 Artificial Intelligence (AI) Stocks on the Market
Via The Motley Fool
Topics Artificial Intelligence
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...'
Via Benzinga
Topics Artificial Intelligence
What Analysts Are Saying About Recursion Pharmaceuticals Stock
Via Benzinga
Is the Market Bullish or Bearish on Recursion Pharmaceuticals?
Via Benzinga
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
Via FinancialNewsMedia
Topics Artificial Intelligence
Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts
Via Benzinga
Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
Via The Motley Fool
Topics Animal Testing Artificial Intelligence Intellectual Property
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
Via The Motley Fool
Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening?
Via Benzinga
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Ahead
Via Stocktwits
Topics Artificial Intelligence Workforce
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?
Via Benzinga
Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT
Via Benzinga
Topics Artificial Intelligence
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
3 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
Topics Energy
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
Via MarketBeat
Topics Artificial Intelligence Earnings
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
Via The Motley Fool
Topics Animal Testing Artificial Intelligence

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.280
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 07/11/25 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 889.29M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 889M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.